Modern Methods of Treatment of "Dry Eye" Syndrome in Women with Menopause

Simple item page
dc.creatorB., Sabirova D.
dc.creatorM., Kadirova A.
dc.creatorA., Khasanova D.
dc.date2022-06-02
dc.date.accessioned2023-08-21T07:33:12Z
dc.date.available2023-08-21T07:33:12Z
dc.descriptionthis article is devoted to the treatment of dry eye syndrome (DES) with tear-replacement monotherapy with eye drops and hormone replacement therapy. According to statistics, women suffer from dry eye syndrome much more often than men. The prevalence of dry eye syndrome (DES), according to various authors, is up to 67% in females over 50 years of age, which is associated with a violation of the hormonal cycle, a change in the functioning of the lacrimal and meibomian glands, leading to a violation of the composition of the tear, and subsequently – to development (SSG).en-US
dc.formatapplication/pdf
dc.identifierhttps://sjii.indexedresearch.org/index.php/sjii/article/view/301
dc.identifier.urihttp://dspace.umsida.ac.id/handle/123456789/10917
dc.languageeng
dc.publisherIndexed Research Publishing Companyen-US
dc.relationhttps://sjii.indexedresearch.org/index.php/sjii/article/view/301/460
dc.rightsCopyright (c) 2022 Spanish Journal of Innovation and Integrityen-US
dc.sourceSpanish Journal of Innovation and Integrity; Vol. 6 (2022): Spanish Journal of Innovation and Integrity; 537-541en-US
dc.source2792-8268
dc.subjectmenopauseen-US
dc.subjectdry eye syndromeen-US
dc.subjecthyperprolactinemiaen-US
dc.subjecttreatment methodsen-US
dc.titleModern Methods of Treatment of "Dry Eye" Syndrome in Women with Menopauseen-US
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion
dc.typePeer-reviewed Articleen-US
Files
Collections
Spanish Journal of Innovation and Integrity